FDA Inspection 1056878 — Novo Nordisk A/S - Hax
The FDA completed an inspection of Novo Nordisk A/S - Hax on May 8, 2018 in Gentofte. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gentofte (Denmark)